1. Home
  2. AXTA vs RGEN Comparison

AXTA vs RGEN Comparison

Compare AXTA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axalta Coating Systems Ltd.

AXTA

Axalta Coating Systems Ltd.

HOLD

Current Price

$34.38

Market Cap

6.3B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$145.13

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXTA
RGEN
Founded
1910
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Paints/Coatings
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.6B
IPO Year
2014
1995

Fundamental Metrics

Financial Performance
Metric
AXTA
RGEN
Price
$34.38
$145.13
Analyst Decision
Buy
Buy
Analyst Count
14
12
Target Price
$35.23
$167.67
AVG Volume (30 Days)
3.0M
971.4K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
286.96
EPS
0.42
0.15
Revenue
$5,117,000,000.00
$141,236,000.00
Revenue This Year
$3.60
$14.30
Revenue Next Year
$3.26
$14.52
P/E Ratio
$82.68
$968.40
Revenue Growth
N/A
35.10
52 Week Low
$24.94
$100.99
52 Week High
$35.72
$175.77

Technical Indicators

Market Signals
Indicator
AXTA
RGEN
Relative Strength Index (RSI) 64.24 70.07
Support Level $33.13 $141.44
Resistance Level $35.72 $172.45
Average True Range (ATR) 0.97 6.22
MACD 0.05 1.41
Stochastic Oscillator 70.19 85.92

Price Performance

Historical Comparison
AXTA
RGEN

About AXTA Axalta Coating Systems Ltd.

Axalta Coating Systems Ltd is a manufacturer, marketer, and distributor of high-performance coatings systems. It operates in two segments: Performance Coatings and Mobility Coatings. The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial, and the Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The majority of its revenue is generated from the Mobility Coatings segment. Geographically, the company generates maximum revenue from the Europe, Middle East and Africa (EMEA) region, followed by North America, Asia Pacific, and Latin America.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: